Plain-English translation of NCT05036226 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 1/2 โ A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This is a Phase I/II trial testing COAST therapy โ a combination of hydroxychloroquine, sirolimus, metformin, and potentially dasatinib and/or nelfinavir โ in patients with advanced cancers that have stopped responding to standard treatments. The trial starts by testing the safety of different combinations of these medications, beginning with three drugs and potentially adding more depending on how well patients tolerate the treatment. The goal is to find the safest and most effective dosing before moving forward with larger studies.
Many patients with advanced cancer run out of standard treatment options, and their disease continues to progress. This medication combination targets a specific process in cancer cells called autophagy, which researchers believe may help slow or stop cancer growth in ways that existing treatments cannot.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will take daily oral medications as part of the study โ starting with a base combination of three drugs, and potentially more depending on which dose level is being studied. Your participation involves regular visits to the research center for blood tests, physical exams, and imaging scans to monitor how your cancer responds and how well you tolerate the medication. The trial begins with careful safety monitoring: early participants receive lower doses while researchers watch closely for any serious side effects before doses are gradually increased for later participants.
AI-generated summary from trial data ยท Jul 15, 2026 ยท Not medical advice
United States